Design, Synthesis and Bioactivity of [3.3.3]Propellane-Based Voltage-Gated Calcium Channel alpha 2 delta Subunit Ligands
文献类型:期刊论文
作者 | He Jinyan1,2,3; Tian Fuyun2,3; Wu Qingqing2; Zheng Yueming3; Chen Yuting2; Xu Haiyan3; Jin Zhengsheng2; Zhan Li3; Cheng Xinqiang2; Gu Yueling3 |
刊名 | CHINESE JOURNAL OF ORGANIC CHEMISTRY |
出版日期 | 2023-06-01 |
卷号 | 43期号:6页码:2226-2238 |
ISSN号 | 0253-2786 |
关键词 | propellane voltage-gated calcium channel alpha 2 delta subunit synthesis bioactivity structure-activity relationship |
DOI | 10.6023/cjoc202210007 |
通讯作者 | Gao Zhaobing(zbgao@simm.ac.cn) ; Zhao Guilong(zhao_guilong@126.com) |
英文摘要 | Voltage-gated calcium channel (VGCC) alpha 2 delta subunit ligands represent one of the most efficacious and safest classes of drugs for the treatment of chronic neuropathic pain. In order to investigate the effect of the sterically bulky alkyl moieties with constrained conformation on the bioactivity of VGCC alpha 2 delta subunit ligands, three.-aminobutyric acids (GABAs) substitued with [3.3.3]propellane and one GABA with bicyclo[3.3.0]octane were designed and synthesized. All the syntheszied compounds were characterzied by H-1 NMR, C-13 NMR and high-resolution mass spectrometry (HRMS), and subjected to in vitro human VGCC alpha 2 delta subunit binding assay. The bioactivity results indicated that: [3.3.3]propellane can be tolerated in the VGCC alpha 2 delta ligand, but its size is bulkier than the optimal size. The amino group in GABA chain can not be modified or replaced; otherwise, the bioactivity will decrease dramatically or even be lost. The structure-activity relationship revealed in the present study may be helpful for the future design of novel VGCC alpha 2 delta subunit ligands. |
WOS关键词 | PHARMACOLOGY ; GABAPENTIN |
资助项目 | Zhongshan Municipal Natural Science Foundation[200805173640573] ; Zhongshan Municipal Natural Science Foundation[210730214049987] ; Guangdong Provincial Basic and Applied Basic Research Foundation[2021A1515010197] ; Guangdong Provincial High-Level New R&D Institute Strategic Special Fund[2019B090904008] ; Guangdong Provincial High-level Innovative Research Institute Strategic Special Fund[2021B0909050003] |
WOS研究方向 | Chemistry |
语种 | 英语 |
出版者 | SCIENCE PRESS |
WOS记录号 | WOS:001028786600028 |
源URL | [http://119.78.100.183/handle/2S10ELR8/306845] |
专题 | 中国科学院上海药物研究所 |
通讯作者 | Gao Zhaobing; Zhao Guilong |
作者单位 | 1.Zunyi Med Univ, Sch Pharm, Zunyi 563003, Guizhou, Peoples R China 2.Chinese Acad Sci, Zhongshan Inst Drug Discovery, Shanghai Inst Mat Med, Guangzhou 528400, Peoples R China 3.Chinese Acad Sci, Shanghai Inst Mat Med, Shanghai 201203, Peoples R China |
推荐引用方式 GB/T 7714 | He Jinyan,Tian Fuyun,Wu Qingqing,et al. Design, Synthesis and Bioactivity of [3.3.3]Propellane-Based Voltage-Gated Calcium Channel alpha 2 delta Subunit Ligands[J]. CHINESE JOURNAL OF ORGANIC CHEMISTRY,2023,43(6):2226-2238. |
APA | He Jinyan.,Tian Fuyun.,Wu Qingqing.,Zheng Yueming.,Chen Yuting.,...&Zhao Guilong.(2023).Design, Synthesis and Bioactivity of [3.3.3]Propellane-Based Voltage-Gated Calcium Channel alpha 2 delta Subunit Ligands.CHINESE JOURNAL OF ORGANIC CHEMISTRY,43(6),2226-2238. |
MLA | He Jinyan,et al."Design, Synthesis and Bioactivity of [3.3.3]Propellane-Based Voltage-Gated Calcium Channel alpha 2 delta Subunit Ligands".CHINESE JOURNAL OF ORGANIC CHEMISTRY 43.6(2023):2226-2238. |
入库方式: OAI收割
来源:上海药物研究所
浏览0
下载0
收藏0
其他版本
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。